The Patent Finder

RSR Limited

Also on record
Records under this name other than the patents RSR Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Back to RSR Limited

PatentTitleStatus Expires Confidence
US 8,110,664Binding partners for the thyrotropin receptor and uses thereof
Term ended
Term ended Apr 5, 2025 · From the USPTO record
Term endedTerm ended Apr 5, 2025From the USPTO record
US 8,129,132Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
Term ended
Term ended Oct 20, 2024 · From the USPTO record
Term endedTerm ended Oct 20, 2024From the USPTO record
US 8,753,637Binding partners for the thyrotropin receptor and uses thereof
Term ended
Ended no later than Nov 28, 2023 · From the USPTO record
Term endedEnded no later than Nov 28, 2023From the USPTO record
US 8,900,823Binding partners for the thyrotropin receptor and uses thereof
Term ended
Term ended Nov 28, 2023 · From the USPTO record
Term endedTerm ended Nov 28, 2023From the USPTO record
US 10,488,410Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
Term ended
Term ended Aug 12, 2023 · From the USPTO record
Term endedTerm ended Aug 12, 2023From the USPTO record
US 10,481,156Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
Term ended
Term ended Aug 8, 2023 · From the USPTO record
Term endedTerm ended Aug 8, 2023From the USPTO record
US 8,298,769Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
Term ended
Term ended Jun 24, 2023 · From the USPTO record
Term endedTerm ended Jun 24, 2023From the USPTO record
US 9,435,797Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
Term ended
Ended no later than Nov 26, 2022 · From the USPTO record
Term endedEnded no later than Nov 26, 2022From the USPTO record
US 8,298,771Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
Term ended
Ended no later than Aug 21, 2022 · From the USPTO record
Term endedEnded no later than Aug 21, 2022From the USPTO record
US 8,309,693Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
Term ended
Term ended Aug 21, 2022 · From the USPTO record
Term endedTerm ended Aug 21, 2022From the USPTO record
10 of 25 patents shown.
Pro members see all 25.
Pro members: see all 25 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited